Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome: Complete Statistical AnalysisIndependent statistical analysis of RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436: Complete Statistical AnalysisIndependent statistical analysis of Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01534897).
- Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients: Complete Statistical AnalysisIndependent statistical analysis of Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00675103).
- Re-expression of ER in Triple Negative Breast Cancers: Complete Statistical AnalysisIndependent statistical analysis of Re-expression of ER in Triple Negative Breast Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01194908).
- Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size…
- RE-PACTIndependent statistical analysis of Respiratory Exacerbation Plans for Action and Care Transitions for Children With Severe CP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REACH 5Independent statistical analysis of Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant: primary endpoint results, effect estimate with confidence…
- REACTIndependent statistical analysis of Safety and Efficacy of Ranibizumab for Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01982435).
- READY-2Independent statistical analysis of Treatment of Moderate to Severe Lateral Canthal Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04249687).
- READY-4Independent statistical analysis of Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study: Complete Statistical AnalysisIndependent statistical analysis of Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Real World Glycemic Effectiveness of Linagliptin: Complete Statistical AnalysisIndependent statistical analysis of Real World Glycemic Effectiveness of Linagliptin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03338803).
- Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO: Complete Statistical AnalysisIndependent statistical analysis of Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients – A Multi Center Chart Review: Complete Statistical AnalysisIndependent statistical analysis of Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review:…
- REAL-ICUIndependent statistical analysis of Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Real-PD Trial: Development of Clinical Prognostic Models for Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Real-PD Trial: Development of Clinical Prognostic Models for Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02474329).
- Real-time fMRI and Neurofeedback of Brain Networks Mediating Trauma Memory Recall in PTSD: Complete Statistical AnalysisIndependent statistical analysis of Real-time fMRI and Neurofeedback of Brain Networks Mediating Trauma Memory Recall in PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor: Complete Statistical AnalysisIndependent statistical analysis of Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05361655).
- Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China: Complete Statistical AnalysisIndependent statistical analysis of Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02668640).
- Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.: Complete Statistical AnalysisIndependent statistical analysis of Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.: primary endpoint results,…
- Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy: Complete Statistical AnalysisIndependent statistical analysis of Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04176354).
- REALIsM-HFIndependent statistical analysis of REALIsM-HF Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03507439).
- REALPAIndependent statistical analysis of Resistance Exercise and Low-Intensity Physical Activity Breaks in Sedentary Time to Improve Muscle and Cardiometabolic Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- REALYSEIndependent statistical analysis of A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE): primary endpoint results, effect estimate with confidence…
- Reanimation in Tetraplegia: Complete Statistical AnalysisIndependent statistical analysis of Reanimation in Tetraplegia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01997125).
- Rebif® Pregnancy Registry: Complete Statistical AnalysisIndependent statistical analysis of Rebif® Pregnancy Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00338741).
- RECAD-AFIndependent statistical analysis of Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Recall by Genotype: Neuropeptide Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Recall by Genotype: Neuropeptide Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05901467).
- RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients: Complete Statistical AnalysisIndependent statistical analysis of RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RECIAIndependent statistical analysis of Multifactorial Approach to Emergent Cerclage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114516).
- ReCLAIM-2Independent statistical analysis of ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01928030).
- RECORD-4Independent statistical analysis of Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01491672).
- RECOVERIndependent statistical analysis of Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00474058).
- Rectal Spacer for Prostate Cancer Radiation Image Guidance: Complete Statistical AnalysisIndependent statistical analysis of Rectal Spacer for Prostate Cancer Radiation Image Guidance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05650021).
- Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis: Complete Statistical AnalysisIndependent statistical analysis of Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial: Complete Statistical AnalysisIndependent statistical analysis of Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00545181).
- Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REDEFINEIndependent statistical analysis of Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REDIRECTIndependent statistical analysis of Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- REDPINEIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19): primary endpoint results, effect…
- Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting: primary endpoint results, effect estimate with confidence…
- Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission: Complete Statistical AnalysisIndependent statistical analysis of Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission: primary endpoint results, effect estimate with confidence…
- Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease: primary endpoint results, effect…
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers: Complete Statistical AnalysisIndependent statistical analysis of Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REDUCEhfIndependent statistical analysis of Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reducing Adolescent Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Reducing Adolescent Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04120376).
- Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients: Complete Statistical AnalysisIndependent statistical analysis of Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…